Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Hemodynamic Monitoring and Resuscitation in Hip Fractures

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03401138
Recruitment Status : Completed
First Posted : January 17, 2018
Last Update Posted : October 30, 2019
Sponsor:
Information provided by (Responsible Party):
Marianne Agerskov, Hvidovre University Hospital

Brief Summary:

Background: Fracture of the hip is a potentially fatal event in an elderly, frail, highly comorbid patient group suffering from dehydration and hypovolemia, and it carries a risk that equals major trauma in young patients in regard of physiological insult and severity, yet no preoperative resuscitation and transfusion strategy is available. An important goal of hemodynamic monitoring and resuscitation is early detection of insufficient tissue perfusion and oxygenation. The peripheral perfusion index reflects changes in peripheral perfusion and blood volume and a decreased peripheral perfusion index predicts surgical complications and morbidity in acute surgical and septic shock patients. The research group hypothesize that elderly frail patients with a fracture of the hip suffer from hypovolemia and peripheral hypoperfusion of varying degrees and accordingly respond to controlled fluid resuscitation and that the non-invasive peripheral perfusion index will serve as an early predictor of a deteriorated circulation in reflection of stroke volume.

Methods: The main objective of this prospective observational study is to assess to what extend patients with fracture of the hip suffer from hypovolemia and respond to a fluid challenge. The secondary objectives are to evaluate correlation between the minimally-invasive measurements of stroke volume and blood volume and the non-invasive measurement of peripheral perfusion index and near-infrared spectroscopy, as well as prevalence of postoperative complications and mortality. Fifty consecutive patients over the age of 65 years, presenting with a hip fracture, treated in a multimodal fast-track regimen, will be included when written informed consent is available. All patients will receive epidural analgesia and preoperative stroke volume-guided hemodynamic optimization. Blood volume measurements are performed and all patients are monitored with peripheral perfusion index and near-infrared spectroscopy.

Discussion: This is likely the first study to address clinically applicable hemodynamic monitoring and resuscitation in patients with fracture of the hip where adequate resuscitation is easily missed. The study group aim to evaluate the feasibility of preoperative stroke volume-guided hemodynamic optimization in the context of minimally- and non-invasive monitoring of peripheral perfusion and blood volume measurements.


Condition or disease Intervention/treatment
Fracture of Hip Other: Preoperative Stroke Volume(SV)-guided fluid optimization

Layout table for study information
Study Type : Observational
Actual Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Preoperative Hemodynamic Monitoring and Resuscitation in Hip Fractures: a Prospective Observational Study
Actual Study Start Date : February 14, 2018
Actual Primary Completion Date : October 28, 2019
Actual Study Completion Date : October 28, 2019

Resource links provided by the National Library of Medicine



Intervention Details:
  • Other: Preoperative Stroke Volume(SV)-guided fluid optimization

    Preoperative SV-guided hemodynamic optimization will be commenced with patients receiving 250ml fluid challenges over five minutes aiming to maximize SV. Maximal SV is defined as absence of a sustained rise in SV by at least 10% in response to a fluid challenge.

    PPI will be obtained from the Masimo Radical 7 (Masimo, Irvine, CA, USA) and NIRS from Invos 5100C (Medtronic, Minneapolis, MN, USA).

    BV measurements will use pulse dye densitometry (PDD) with Indocyanine Green (ICG). We will use the Dye Densitogram 3300 analyser Nihon Kohden (Tokyo, Japan) for registration of the spectrophotometrical absorption of ICG and calculation of BV.

    Other Names:
    • Blood volume measurement
    • Monitoring of Peripheral Perfusion Index (PPI)
    • Monitoring of Near-infrared Spectroscopy (NIRS)


Primary Outcome Measures :
  1. Proportion of patients presenting with preoperative hypovolemia/reduced BV before and after epidural anesthesia [ Time Frame: Preoperatively ]
  2. Proportion of patients with low/very low PPI (PII<1.4 and < 0.5) before and after epidural anesthesia [ Time Frame: Preoperatively ]
  3. Proportion of patients who respond to a 250 ml fluid challenge with sustained rise in SV by at least 10% [ Time Frame: Preoperatively ]

Secondary Outcome Measures :
  1. Correlation between SV, PII and NIRS at normo- and hypovolemia states [ Time Frame: Preoperatively ]
  2. Correlation between PPI and standard microcirculatory variables including lactate, capillary refill time (CRT), and central vs. peripheral temperature [ Time Frame: Preoperatively ]
  3. Correlation between non-invasive Hemoglobin (Hb), BV and arterial Hb [ Time Frame: Preoperatively ]
  4. Proportion of mortality in patients responding to the fluid challenge vs. patients not responding [ Time Frame: At 30 days and 1 year ]
  5. Proportion of postoperative complications in patients responding to the fluid challenge vs. patients not responding [ Time Frame: At 30 days and 1 year ]
  6. Proportion of mortality in patients with high vs. low PPI and NIRS, including impact of BV [ Time Frame: At 30 days and 1 year ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients presenting a primary acute HF within the study period will be screened for participation by the attending anesthesiologist at the post-anesthesia care unit. The study manager will verify the inclusion and exclusion criteria and inform patients (verbally and in writing) and confirm their agreement to participate by asking them to sign the informed consent document. Assessment of electronic patient records, monitoring and resuscitation treatment and recording of data will be by the study manager.
Criteria

Inclusion Criteria:

  • Primary acute hip fracture
  • Age grater than 65 years
  • Written informed consent

Exclusion Criteria:

- Contraindications to epidural analgesia


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03401138


Locations
Layout table for location information
Denmark
Department af Anesthesia, Hvidovre Hospital
Hvidovre, Copenhagen, Denmark, 2650
Sponsors and Collaborators
Hvidovre University Hospital
Investigators
Layout table for investigator information
Study Director: Nicolai Bang Foss, Clinical Professor Department of Anesthesia, Hvidovre Hospital
Study Chair: Jakob Højlund, MD, Senior Hospital Physiscian Department of Anesthesia, Hvidovre Hospital
Study Chair: Henrik Sørensen, MD, DMSc Abdominal Centre, Department of Anesthesia, Rigshospitalet
Study Chair: Niels Secher, Professor, DMSc Abdominal Centre, Department of Anesthesia, Rigshospitalet
Principal Investigator: Marianne Agerskov, MD, Research Fellow Department of Anesthesia, Hvidovre Hospital
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Marianne Agerskov, MD, Reseach Fellow, Hvidovre University Hospital
ClinicalTrials.gov Identifier: NCT03401138    
Other Study ID Numbers: H- 17037633
First Posted: January 17, 2018    Key Record Dates
Last Update Posted: October 30, 2019
Last Verified: October 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Marianne Agerskov, Hvidovre University Hospital:
Peripheral perfusion
Blood Volume
Tissue Prefusion
Near-infrared spectroscopy
Hemodynamic monitoring
Hemodynamic optimization
Preoperative resuscitation
Additional relevant MeSH terms:
Layout table for MeSH terms
Fractures, Bone
Hip Fractures
Wounds and Injuries
Femoral Fractures
Hip Injuries
Leg Injuries